Literature DB >> 26416005

Mechanisms underlying trastuzumab activity are complex.

Michael S Ewer1, Steven M Ewer2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26416005     DOI： 10.1038/nrcardio.2015.136

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  3 in total

1.  Trastuzumab is not a tyrosine kinase inhibitor.

Authors:  Nishant Mohan; Wen Jin Wu
Journal:  Nat Rev Cardiol       Date:  2015-09-29       Impact factor: 32.419

2.  Cardiotoxicity of anticancer treatments.

Authors:  Michael S Ewer; Steven M Ewer
Journal:  Nat Rev Cardiol       Date:  2015-08-20       Impact factor: 32.419

Review 3.  Cardiotoxicity of anticancer treatments.

Authors:  Michael S Ewer; Steven M Ewer
Journal:  Nat Rev Cardiol       Date:  2015-05-12       Impact factor: 32.419
  3 in total
  1 in total

Review 1.  In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation.

Authors:  Serena L'Abbate; Michela Chianca; Iacopo Fabiani; Annamaria Del Franco; Alberto Giannoni; Giuseppe Vergaro; Chrysanthos Grigoratos; Claudia Kusmic; Claudio Passino; Yuri D'Alessandra; Silvia Burchielli; Michele Emdin; Daniela Maria Cardinale
Journal:  J Cardiovasc Transl Res       Date:  2022-03-21       Impact factor: 4.132
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.